The increasing demand for isotopically labeled compounds has provided an appreciable impetus for the development of improved methods for the late-stage introduction of isotopes of hydrogen (deuterium or tritium). Moreover, sp3-rich molecules are becoming increasingly common in the exploration of chemical space for drug design. Herein, we report an efficient iridium(I)-catalyzed C–H activation method for the hydrogen isotope exchange of sp3 C–H bonds. A wide range of substrates have been labeled, including active pharmaceutical ingredients, delivering excellent levels of isotope incorporation and predictable regiocontrol, with low catalyst loadings, in short reaction times, and under mild reaction conditions.
No takes yet. Share an insight, caveat, or question.
Kerr et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: